Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma

This phase I/II study was conducted to evaluate the feasibility, safety and efficacy of immunotherapy using tumor lysate (TL)-pulsed dendritic cells (DC) in patients with metastatic renal cell carcinoma (RCC). DC were generated by culturing peripheral blood mononuclear cells in the presence of GM-CS...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 125(2007), 3 vom: 01. Dez., Seite 257-67
1. Verfasser: Kim, Jung Han (VerfasserIn)
Weitere Verfasser: Lee, Yoon, Bae, Yong-Soo, Kim, Won Seog, Kim, Kihyun, Im, Ho Yeong, Kang, Won Ki, Park, Keunchil, Choi, Han Yong, Lee, Hyun Moo, Baek, So-Young, Lee, Hyunah, Doh, Hyounmie, Kim, Byong-Moon, Kim, Chae Young, Jeon, ChoonJu, Jung, Chul Won
Format: Aufsatz
Sprache:English
Veröffentlicht: 2007
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Clinical Trial, Phase I Clinical Trial, Phase II Journal Article Research Support, Non-U.S. Gov't Antigens, Neoplasm Cytokines Interferon-gamma 82115-62-6 Hemocyanins 9013-72-3 mehr... keyhole-limpet hemocyanin FV4Y0JO2CX